Jon Hartas

890 total citations
22 papers, 720 citations indexed

About

Jon Hartas is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jon Hartas has authored 22 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 14 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Jon Hartas's work include Streptococcal Infections and Treatments (19 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Neonatal and Maternal Infections (12 papers). Jon Hartas is often cited by papers focused on Streptococcal Infections and Treatments (19 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Neonatal and Maternal Infections (12 papers). Jon Hartas collaborates with scholars based in Australia, United States and Italy. Jon Hartas's co-authors include Kadaba S. Sriprakash, Michael R. Batzloff, Michael F. Good, Manisha Pandey, Bart J. Currie, Don L. Gardiner, John D. Mathews, David C. Jackson, Darrell J. Kemp and Weiguang Zeng and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Genome Research.

In The Last Decade

Jon Hartas

22 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Hartas Australia 16 547 464 142 116 113 22 720
Amanda J. Cork Australia 17 609 1.1× 433 0.9× 160 1.1× 130 1.1× 44 0.4× 22 784
Totolian Aa Russia 12 420 0.8× 292 0.6× 129 0.9× 106 0.9× 41 0.4× 58 562
José Delgado-Domínguez Mexico 16 451 0.8× 181 0.4× 306 2.2× 106 0.9× 266 2.4× 30 853
Margriet Jansze Netherlands 16 155 0.3× 213 0.5× 207 1.5× 174 1.5× 181 1.6× 34 649
Kellie Burnside United States 14 298 0.5× 217 0.5× 248 1.7× 250 2.2× 70 0.6× 17 721
Prathiba Kurupati United Kingdom 11 181 0.3× 177 0.4× 84 0.6× 156 1.3× 159 1.4× 12 560
Andrew Heath United States 9 616 1.1× 527 1.1× 132 0.9× 58 0.5× 36 0.3× 10 696
Eugene H. Burns United States 8 334 0.6× 275 0.6× 75 0.5× 70 0.6× 56 0.5× 10 443
Josephine Weber-Heynemann Germany 7 491 0.9× 259 0.6× 170 1.2× 50 0.4× 42 0.4× 8 576
Eugene N. Fox United States 16 564 1.0× 260 0.6× 189 1.3× 195 1.7× 118 1.0× 28 720

Countries citing papers authored by Jon Hartas

Since Specialization
Citations

This map shows the geographic impact of Jon Hartas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Hartas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Hartas more than expected).

Fields of papers citing papers by Jon Hartas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Hartas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Hartas. The network helps show where Jon Hartas may publish in the future.

Co-authorship network of co-authors of Jon Hartas

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Hartas. A scholar is included among the top collaborators of Jon Hartas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Hartas. Jon Hartas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sekuloski, Silvana, Michael R. Batzloff, Paul Griffin, et al.. (2018). Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLoS ONE. 13(7). e0198658–e0198658. 68 indexed citations
3.
Moyle, Peter M., Jon Hartas, Anna Henningham, et al.. (2013). An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system. Nanomedicine Nanotechnology Biology and Medicine. 9(7). 935–944. 29 indexed citations
4.
Rivera-Hernández, Tania, Jon Hartas, Yang Wu, et al.. (2013). Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS). Vaccine. 31(15). 1950–1955. 33 indexed citations
5.
Jia, Zhongfan, Mehfuz Zaman, Jon Hartas, et al.. (2013). Polymer–Peptide Hybrids as A Highly Immunogenic Single-Dose Nanovaccine. Nanomedicine. 9(1). 35–43. 43 indexed citations
6.
Henningham, Anna, Emiliano Chiarot, Christine M. Gillen, et al.. (2012). Conserved anchorless surface proteins as group A streptococcal vaccine candidates. Journal of Molecular Medicine. 90(10). 1197–1207. 49 indexed citations
7.
Steer, Andrew C., Adam Jenney, Frances Oppedisano, et al.. (2007). High burden of invasive β-haemolytic streptococcal infections in Fiji. Epidemiology and Infection. 136(5). 621–627. 39 indexed citations
9.
Batzloff, Michael R., Mark R. Davies, Jon Hartas, et al.. (2005). Toward the Development of an Antidisease, Transmission‐Blocking Intranasal Vaccine for Group A Streptococcus. The Journal of Infectious Diseases. 192(8). 1450–1455. 41 indexed citations
10.
Batzloff, Michael R., et al.. (2004). Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection.. PubMed. 119 Suppl. 104–7. 31 indexed citations
11.
Sriprakash, Kadaba S., Jon Hartas, & Andrew White. (2002). Antibodies to streptococcal inhibitor of complement function and M peptides in a post-streptococcal glomerulonephritis endemic region of Australia.. Journal of Medical Microbiology. 51(7). 589–650. 18 indexed citations
12.
Hartas, Jon & Kadaba S. Sriprakash. (1999). Streptococcus pyogenesstrains containingemm12 andemm55 possess a novel gene coding for distantly related SIC protein. Microbial Pathogenesis. 26(1). 25–33. 39 indexed citations
13.
Hartas, Jon, et al.. (1998). Simplification of a Locus-Specific DNA Typing Method (Vir Typing) for Streptococcus pyogenes. Journal of Clinical Microbiology. 36(5). 1428–1429. 32 indexed citations
14.
Sriprakash, Kadaba S. & Jon Hartas. (1997). Genetic Mosaic Upstream of scpG in Human Group G Streptococci Contains Sequences from Group A Streptococcal Virulence Regulon. Advances in experimental medicine and biology. 418. 749–751. 8 indexed citations
15.
Gardiner, Don L., et al.. (1997). Molecular Epidemiology of Group A Streptococcal Infection in the Northern Territory of Australia. Advances in experimental medicine and biology. 418. 317–321. 10 indexed citations
16.
Sriprakash, Kadaba S. & Jon Hartas. (1996). Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing. Microbial Pathogenesis. 20(5). 275–285. 35 indexed citations
18.
Gardiner, Don L., Jon Hartas, Bart J. Currie, et al.. (1995). Vir typing: a long-PCR typing method for group A streptococci.. Genome Research. 4(5). 288–293. 69 indexed citations
19.
Hartas, Jon, et al.. (1992). Oligonucleotide probes to identify three sibling species of the Anopheles farauti Laveran complex (Diptera: Culicidae). Transactions of the Royal Society of Tropical Medicine and Hygiene. 86(2). 210–212. 5 indexed citations
20.
Sriprakash, Kadaba S. & Jon Hartas. (1989). Hairpin extension a general method for the improvement of sensitivity of oligonucleotide probes. PubMed. 6(2). 29–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026